Salarius Pharmaceuticals, LLC   Report issue

For profit Phase 1 Phase 2
Founded: Houston TX United States (2010)
Status: Acquired by Flex Pharma, Inc. (2019)

Organization Overview

First Clinical Trial
2018
NCT03600649
First Marketed Drug
2018
sevelamer (renagel)
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

ARTHUR GRP | Salarius Pharmaceuticals, LLC